Publications by authors named "Yelenis Seijo De Armas"

Article Synopsis
  • The study investigates different heart failure (HF) types in patients diagnosed with transthyretin cardiac amyloidosis (ATTR-CA), revealing that a significant portion present with impaired systolic function, specifically heart failure with reduced ejection fraction (HFrEF) or mildly reduced ejection fraction (HFmrEF).
  • A retrospective analysis of patients from 2016 to 2022 found that 21.6% had HFrEF, 17.8% had HFmrEF, and 60.6% had heart failure with preserved ejection fraction (HFpEF), indicating a notable prevalence of systolic dysfunction in ATTR-CA cases.
  • The findings suggest that clinicians should maintain a high level of suspicion
View Article and Find Full Text PDF
Article Synopsis
  • This study examines the risk factors for worsening renal function (wRF) in patients with transthyretin cardiac amyloidosis (ATTR-CA), which is linked to poor outcomes.
  • Out of 134 patients studied, 41.8% experienced wRF within the first year, with significant predictors being a higher New York Heart Association (NYHA) class, a lack of prior ischemic heart disease, and not being on SGLT-2 inhibitors.
  • The findings highlight that renal dysfunction is a common issue after ATTR-CA diagnosis, indicating that certain patient characteristics can help forecast who is at greater risk for developing wRF.
View Article and Find Full Text PDF

Background  The first-line imaging for low to medium-risk patients presenting to the emergency department with stable chest pain is often a matter of debate. Chest pain is the second most common presentation to the emergency department. Non-invasive imaging has been useful in assisting in the diagnosis of coronary artery disease.

View Article and Find Full Text PDF

Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometabolic clinical catastrophe. Based on the scalable heterogeneity from a cellular level to healthcare systems in the hemodynamic-based management of patients experiencing CS, the authors present considerations towards systematic hemodynamic-based transitions in which distinct clinical entities share the common path of early identification and rapid transitions through an adaptive longitudinal situational awareness model of care that influences specific management considerations.

View Article and Find Full Text PDF

Arrhythmogenic right ventricular cardiomyopathy and cardiac sarcoidosis can both present with ventricular tachycardia. We report a case of a patient whose histological diagnosis was not only confirmed by the transplanted heart but who also underwent successful transplantation after overcoming COVID-19. < Similarities in the clinical presentation of cardiac sarcoidosis (CS) and arrhythmogenic right ventricular cardiomyopathy (ARVC) Management differences between CS and ARVC Successful heart transplantation after COVID-19.

View Article and Find Full Text PDF